On January 21, Governor Mike DeWine announced that the state is purchasing 2 million at-home, rapid COVID-19 tests using telehealth services where the results are delivered in minutes without the need to send the test to a lab for processing. Developed by Abbott, BinaxNOW is an easy-to-use antigen test that detects the virus when people are most infectious.
To facilitate the delivery of the BinaxNOW test to the home and the guided collection and testing process, Abbott has partnered with digital health solutions provider eMed™, who will deliver people their results through Abbott’s complementary NAVICA™app in a matter of minutes. eMed™ will report the rapid test results in the electronic lab reporting system.
“Abbott has been a valued partner throughout this pandemic and this new partnership will help us continue aggressive testing at colleges and universities, and pursue access to rapid testing in every county in Ohio,” said Gov. DeWine. “These tests combined with the telehealth solutions provided by eMed™ will provide equitable access to testing for those who may not be able to access traditional testing because of their working hours, have mobility or transportation issues, or have caregiving responsibilities.”
“The partnership with the State of Ohio is proof of our ability to get millions of tests in the hands of people who need them,” said Patrice Harris, MD, MA, eMed CEO. “We are proud of this joint accomplishment which fortifies our belief that serial testing, when deployed in accordance with public health best practices, the Centers for Disease Control and Prevention, and Food and Drug Administration guidance, plays a critical role in mitigating the spread of COVID-19 and getting our society and economy on the right track.”
This partnership will provide at least 2 million of the BinaxNow tests for Ohioans as, Abbot, eMed™, and the Ohio Department of Health pursue innovative efforts to end the COVID-19 pandemic.